1OA Stock Chart & Stats
€0.01
>-€0.01(-45.00%)
At close: 4:00 PM EST
€0.01
>-€0.01(-45.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.02
Previous CloseN/A
Volume135.00K
Average Volume (3M)52.63K
Market Cap
€4.63M
Enterprise Value€4.94
Total Cash (Recent Filing)€14.77K
Total Debt (Recent Filing)€8.28K
Price to Earnings (P/E)―
Beta-0.20
Next Earnings
Nov 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding495,090,100
10 Day Avg. Volume52,630
30 Day Avg. Volume52,630
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)14.73
Price to Sales (P/S)15.15
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Gross MarginThe substantial gross-margin improvement indicates better economics on each unit of revenue and provides a stronger base for future operating leverage. However, the benefit will only become durable if revenue scale increases enough to absorb the company’s still-heavy operating cost structure.
Moderate LeverageLow absolute debt and reduced leverage limit fixed financial obligations relative to earlier periods, preserving more flexibility for capital allocation. This is a fundamental balance-sheet positive, although the advantage is partly offset by the company’s sharply diminished equity base.
Reduced Cash BurnThe improvement in operating and free-cash-flow losses suggests some progress in controlling cash consumption. If maintained, a lower burn rate could extend financial flexibility and reduce funding pressure, although operations still do not generate the internal cash needed to support growth.
Bears Say
Declining RevenueA shrinking and uneven revenue base limits operating leverage and makes it harder to spread fixed costs across a larger business. Continued top-line weakness would constrain reinvestment capacity and delay any credible transition from restructuring or stabilization toward sustainable growth.
Severe Operating LossesExtremely negative operating and net margins show that current revenue is far below the level required to cover the cost base. Even with improved gross margin, the scale of losses indicates that substantial operating discipline or revenue expansion is needed before profitability can become sustainable.
Eroded Equity BaseThe sharp contraction in equity reflects the cumulative impact of ongoing losses and leaves a much thinner balance-sheet cushion. That reduced base increases financial flexibility risk, while deeply negative ROE signals that existing shareholder capital is not currently producing economic returns.
Blueberries Medical News
1OA FAQ
What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was <€0.01 and its highest was €0.02 in the past 12 months.
What is Blueberries Medical Corp’s market cap?
Blueberries Medical Corp’s market cap is €4.63M.
When is Blueberries Medical Corp’s upcoming earnings report date?
Blueberries Medical Corp’s upcoming earnings report date is Nov 30, 2026 which is in 82 days.
How were Blueberries Medical Corp’s earnings last quarter?
Blueberries Medical Corp released its earnings results on Aug 31, 2026. The company reported €0 earnings per share for the quarter.
Is Blueberries Medical Corp overvalued?
According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued.
Does Blueberries Medical Corp pay dividends?
Blueberries Medical Corp does not currently pay dividends.
What is Blueberries Medical Corp’s EPS estimate?
Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blueberries Medical Corp have?
Blueberries Medical Corp has 495,090,100 shares outstanding.
What happened to Blueberries Medical Corp’s price movement after its last earnings report?
Blueberries Medical Corp reported an EPS of €0 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Blueberries Medical Corp?
Currently, no hedge funds are holding shares in DE:1OA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blueberries Medical Corp
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and its associated products across Colombia. Their offerings notably include medicinal cannabis oil extracts and other complementary items.